                         SEQUENCE LISTING

<110>  LI-COR, Inc.
 
<120>  PHTHALOCYANINE PROBES AND USES THEREOF

<130>  85409-946834

<140>  PCT/US2015/033759
<141>  2015-06-02

<150>  US 62/006,790
<151>  2014-06-02

<150>  US 62/017,165
<151>  2014-06-25

<150>  US 62/066,807
<151>  2014-10-21

<150>  US 62/082,052
<151>  2014-11-19

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  53
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Epidermal growth factor

<400>  1

Asn Ser Asp Ser Glu Cys Pro Leu Ser His Asp Gly Tyr Cys Leu His 
1               5                   10                  15      


Asp Gly Val Cys Met Tyr Ile Glu Ala Leu Asp Lys Tyr Ala Cys Asn 
            20                  25                  30          


Cys Val Val Gly Tyr Ile Gly Glu Arg Cys Gln Tyr Arg Asp Leu Lys 
        35                  40                  45              


Trp Trp Glu Leu Arg 
    50              


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sytnthetic Construct, WP9QY, TNF - alpha Antagonist

<400>  2

Tyr Cys Trp Ser Gln Tyr Leu Cys Tyr 
1               5                   


<210>  3
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic vasoactive intestinal peptide (VIP)

<400>  3

His Ser Asp Ala Val Phe Thr Asp Asn Tyr Thr Arg Leu Arg Lys Gln 
1               5                   10                  15      


Met Ala Val Lys Lys Tyr Leu Asn Ser Ile Leu Asn 
            20                  25              


<210>  4
<211>  14
<212>  PRT
<213>  Bombina bombina


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa= Pyroglutamic acid

<400>  4

Xaa Gln Arg Leu Gly Asn Gln Trp Ala Val Gly His Leu Met 
1               5                   10                  


<210>  5
<211>  11
<212>  PRT
<213>  Homo sapiens

<400>  5

Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met 
1               5                   10      


<210>  6
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  6

Cys Phe Gly Ile Lys Gln Lys Asp Ile Asp Lys Asp Leu Val Ile 
1               5                   10                  15  


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sytnthetic Construct, Octreotide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa = D-Phenylalanine

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa = D-Tryptophan

<400>  7

Xaa Cys Phe Xaa Lys Thr Cys Thr 
1               5               


<210>  8
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct, Exendin-4

<400>  8

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  9
<211>  13
<212>  PRT
<213>  Blarina brevicauda

<400>  9

Lys Glu Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
1               5                   10              


<210>  10
<211>  27
<212>  PRT
<213>  Blarina brevicauda

<400>  10

Glu Gly Lys Leu Ser Ser Asn Asp Thr Glu Gly Gly Leu Cys Lys Glu 
1               5                   10                  15      


Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
            20                  25          


<210>  11
<211>  54
<212>  PRT
<213>  Blarina brevicauda

<400>  11

Asp Cys Ser Gln Asp Cys Ala Ala Cys Ser Ile Leu Ala Arg Pro Ala 
1               5                   10                  15      


Glu Leu Asn Thr Glu Thr Cys Ile Leu Glu Cys Glu Gly Lys Leu Ser 
            20                  25                  30          


Ser Asn Asp Thr Glu Gly Gly Leu Cys Lys Glu Phe Leu His Pro Ser 
        35                  40                  45              


Lys Val Asp Leu Pro Arg 
    50                  


<210>  12
<211>  36
<212>  PRT
<213>  Leiurus quinquestriatus

<400>  12

Met Cys Met Pro Cys Phe Thr Thr Asp His Gln Met Ala Arg Lys Cys 
1               5                   10                  15      


Asp Asp Cys Cys Gly Gly Lys Gly Arg Gly Lys Cys Tyr Gly Pro Gln 
            20                  25                  30          


Cys Leu Cys Arg 
        35      


<210>  13

<400>  13
000

